Comprehensive genomic profiles of small cell lung cancer J George, JS Lim, SJ Jang, Y Cun, L Ozretić, G Kong, F Leenders, X Lu, ... Nature 524 (7563), 47-53, 2015 | 2041 | 2015 |
KRAS dimerization impacts MEK inhibitor sensitivity and oncogenic activity of mutant KRAS C Ambrogio, J Köhler, ZW Zhou, H Wang, R Paranal, J Li, M Capelletti, ... Cell 172 (4), 857-868. e15, 2018 | 265 | 2018 |
Diarrhea associated with afatinib: an oral ErbB family blocker JCH Yang, N Reguart, J Barinoff, J Köhler, M Uttenreuther-Fischer, ... Expert Review of Anticancer Therapy 13 (6), 729-736, 2013 | 130 | 2013 |
Integrated 18F-FDG PET/MR imaging in the assessment of cardiac masses: a pilot study F Nensa, E Tezgah, TD Poeppel, CJ Jensen, J Schelhorn, J Köhler, ... Journal of Nuclear Medicine 56 (2), 255-260, 2015 | 124 | 2015 |
Thoracic staging in lung cancer: prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT P Heusch, C Buchbender, J Köhler, F Nensa, T Gauler, B Gomez, H Reis, ... Journal of Nuclear Medicine 55 (3), 373-378, 2014 | 123 | 2014 |
Afatinib, erlotinib and gefitinib in the first-line therapy of EGFR mutation-positive lung adenocarcinoma: a review J Köhler, M Schuler Onkologie 36 (9), 510-518, 2013 | 120 | 2013 |
Diagnostic accuracy of whole-body PET/MRI and whole-body PET/CT for TNM staging in oncology P Heusch, F Nensa, B Schaarschmidt, R Sivanesapillai, K Beiderwellen, ... European journal of nuclear medicine and molecular imaging 42, 42-48, 2015 | 75 | 2015 |
Induction of protective immunity against Burkholderia pseudomallei using attenuated mutants with defects in the intracellular life cycle K Breitbach, J Köhler, I Steinmetz Transactions of the Royal Society of Tropical Medicine and Hygiene 102 …, 2008 | 73 | 2008 |
Development of a highly sensitive and specific method for detection of circulating tumor cells harboring somatic mutations in non-small-cell lung cancer patients F Breitenbuecher, S Hoffarth, K Worm, D Cortes-Incio, TC Gauler, J Köhler, ... PLoS One 9 (1), e85350, 2014 | 65 | 2014 |
Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in lymph node metastases of non-small cell lung cancer (NSCLC) patients using … BM Schaarschmidt, C Buchbender, F Nensa, J Grueneien, B Gomez, ... PLoS One 10 (1), e0116277, 2015 | 56 | 2015 |
Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions … P Heusch, C Buchbender, J Köhler, F Nensa, K Beiderwellen, H Kühl, ... RöFo-Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden …, 2013 | 55 | 2013 |
Caspase-1 mediates resistance in murine melioidosis K Breitbach, GW Sun, J Köhler, K Eske, P Wongprompitak, G Tan, Y Liu, ... Infection and immunity 77 (4), 1589-1595, 2009 | 51 | 2009 |
Generation of murine bone marrow derived macrophages in a standardised serum-free cell culture system K Eske, K Breitbach, J Köhler, P Wongprompitak, I Steinmetz Journal of immunological methods 342 (1-2), 13-19, 2009 | 49 | 2009 |
Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients J Köhler, M Schuler, TC Gauler, S Nöpel-Dünnebacke, M Ahrens, ... Journal of cancer research and clinical oncology 142, 795-805, 2016 | 45 | 2016 |
Quantitative assessment of small bowel motility in patients with Crohn's disease using dynamic MRI ML Hahnemann, F Nensa, S Kinner, J Köhler, G Gerken, L Umutlu, ... Neurogastroenterology & Motility 27 (6), 841-848, 2015 | 42 | 2015 |
Oncogenic RAS simultaneously protects against anti-EGFR antibody-dependent cellular cytotoxicity and EGFR signaling blockade S Kasper, F Breitenbuecher, H Reis, S Brandau, K Worm, J Köhler, A Paul, ... Oncogene 32 (23), 2873-2881, 2013 | 39 | 2013 |
Hybrid [18F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC) P Heusch, J Köhler, HJ Wittsack, TA Heusner, C Buchbender, TD Poeppel, ... European Journal of Radiology 82 (11), 2055-2060, 2013 | 38 | 2013 |
MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer S Kitajima, T Tani, BF Springer, M Campisi, T Osaki, K Haratani, M Chen, ... Cancer Cell 40 (10), 1128-1144. e8, 2022 | 37 | 2022 |
NADPH-oxidase but not inducible nitric oxide synthase contributes to resistance in a murine Staphylococcus aureus Newman pneumonia model J Köhler, K Breitbach, C Renner, AK Heitsch, A Bast, N Van Rooijen, ... Microbes and infection 13 (11), 914-922, 2011 | 37 | 2011 |
EGFR Inhibition Enhances the Cellular Uptake and Antitumor-Activity of the HER3 Antibody–Drug Conjugate HER3–DXd HM Haikala, T Lopez, J Köhler, PO Eser, M Xu, Q Zeng, TJ Teceno, K Ngo, ... Cancer research 82 (1), 130-141, 2022 | 36 | 2022 |